A slew of hedge funds that invest in private companies — including Citadel’s Surveyor Capital and Dan Sundheim’s D1 Capital Management — are anticipating at least four fledgling health care companies planning to go public in the near future.
In the past two days, two of the companies set terms for their IPOs while two other biopharma
The Renaissance IPO index has returned 51.6
